Market: Automotive , Motorcycles , Rail Transport , General Automotive / Transport , General services , Industrial / Manufacturing , Chemicals , Metals & Minerals , General Industry / Manufacturing , Pharmaceuticals / Health , Health Care , Hospitals / Pharmacies , General Pharmaceuticals / Health
|
2010 |
320,00€ |
Mammography World Markets
The women’s mammography segment is poised for a major new phase of growth fueled by the availability of new technology coming out of the computer and digital areas and the higher i
Market: Health Care
|
2010 |
3.400,00$ |
Global Life & Health Insurance
Datamonitor's Global Life & Health Insurance industry profile is an essential resource for top-level data and analysis covering the Life & Health Insurance industry. It includes da
Market: General insurance , Health Care
|
2010 |
250,00$ |
Global Advanced Wound Management: Market Analysis and Opportunity Assessment
Introduction
GlobalData’s “Global Advanced Wound Management: Market Analysis and Opportunity Assessment” report is an essential source of data and analysis on the global advance
Market: Health Care & Medical Products , Health Care
|
2009 |
3.500,00$ |
Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016
Introduction
GlobalData’s “Negative Pressure Wound Therapy (NPWT)Pipeline Technology and Market Forecasts to 2016” report is an essential source of information and analysis on t
Market: Health Care
|
2009 |
2.000,00$ |
Commercial Insight: Cardiovascular and metabolic market overview Diabetes to the fore as generics hit primary care markets
A detailed clinical and commercial assessment of all key cardiovascular and metabolic therapy areas. / / An analysis of the portfolios of top 10 leading cardiovascular and metabolic companies. / / Sales based sales forecasts for all key cardiovascular and metabolic active agents in the seven major
Market: Health Care
|
2009 |
15.200,00$ |
Global Ophthalmic Market: Focus on Glaucoma
The report focuses on glaucoma as a major ophthalmic market. The various aspects of glaucoma are discussed like glaucoma as a disease, types of glaucoma, and treatment of glaucoma. Global as well as US market size and forecasts are given for ophthalmic as well as glaucoma market. The market trends a
Market: Health Care , Diagnostics / Medical technology
|
2009 |
800,00$ |
Global Medical Tourism
The wealthy citizens of developing countries have frequently traveled to the U.S. and Western Europe to seek the expertise and gain access to advanced technology available at leadi
Market: Health Care
|
2008 |
1.999,00$ |
Report for the investigation of chinese medical and pharmaceutical CRO market (2008)
Market: Health Care
|
2008 |
1.500,00$ |
The Top Ten Specialty Pharmaceutical Companies: Positioning, performance and SWOT analyses
The Top Ten Specialty Pharmaceutical Companies
Positioning, performance and SWOT analyses
Specialty pharmaceutical companies focus the majority of their efforts upon one or two th
Market: Health Care
|
2008 |
3.835,00$ |
The Promotional Landscape in US and Europe: Benchmarking promotional ROI and optimizing detailing and journal spend
The Promotional Landscape in the US and Europe
Benchmarking promotional ROI and optimizing detailing and journal spend relationships
Promotional activities within the pharma indus
Market: Health Care
|
2008 |
3.835,00$ |
The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
The dermatology market remains highly competitive, with developers ranging from Big Pharma to biotechnology and specialty pharmaceutical firms. In recent years levels of innovation
Market: Health Care
|
2008 |
3.835,00$ |
Biotech M&A Strategies: Deal assessments, trends and future prospects
M&A activity in the pharma industry continues to gain momentum as a growing number of companies seek to replenish drug pipelines through biotechnology acquisitions. M&As be
Market: Health Care
|
2008 |
3.835,00$ |
AstraZeneca plc: PharmaVitae Profile
This analysis examines the historical and forecast performance for AstraZeneca in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and
Market: Health Care
|
2008 |
5.700,00$ |
Pipeline Insight: Insulin antidiabetics - Return to injections alternative delivery methods fall by the wayside
Comprehensive analysis of the current insulin antidiabetic pipeline detailing the broad range of developmental classes. / / A detailed clinical and commercial assessment of all key emerging therapies. / / Sales based sales forecasts for key late-stage developmental non-insulin antidiabetics agents
Market: Health Care
|
2008 |
11.400,00$ |
Commercial Insight: Targeted Therapy Cancer Brands - High growth market will see eight new blockbusters by 2017
Forecast sales of every marketed targeted therapy cancer brand in each of the seven major markets over the period 2007 to 2017
/
/ Analysis and segmentation of the market at various levels including drug class, indication, company and mode of administration
/
/ Comprehensive brand profiles and
Market: Health Care
|
2008 |
15.200,00$ |
Johnson & Johnson: PharmaVitae Profile
This analysis examines the historical and forecast performance for J&J in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline
Market: Health Care
|
2008 |
5.700,00$ |
Stakeholder Opinions: Diagnostics in Neurology - Predictive biomarkers expand drug revenues
Neurological conditions covered: Alzheimer's disease, Parkinson's disease, MS, epilepsy, migraine, insomnia, Huntington's disease and ALS. / / Overview of key biomarkers in development for each condition (including genetics). / / Identification of key factors required for the commercial success of
Market: Health Care
|
2008 |
3.800,00$ |
Commercial Insight: Cytotoxic Therapy Cancer Brands - Looming patent expiries limit market growth
Analysis of the performance of each of the cytotoxic therapy cancer brands in the seven major markets, forecast to 2017
/
/ Analysis and segmentation of the market at various levels including drug class, indication, company and sales growth rate
/
/ Assessment of the leading cancer brands and
Market: Health Care
|
2008 |
15.200,00$ |
Wyeth: PharmaVitae Profile
This analysis examines the historical and forecast performance for Wyeth in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and p
Market: Health Care
|
2008 |
5.700,00$ |
Schering-Plough Corporation: PharmaVitae Profile
This analysis examines the historical and forecast performance for Schering-Plough in the ethical pharma sector. The profile encompasses global company strategy, portfolio and pipe
Market: Health Care
|
2008 |
5.700,00$ |
Bristol-Myers Squibb Co.: PharmaVitae Profile
This analysis examines the historical and forecast performance for BMS in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline
Market: Health Care
|
2008 |
5.700,00$ |
Bayer Schering Pharma AG: PharmaVitae Profile
This analysis examines the historical and forecast performance for Bayer Schering Pharma in the ethical pharma sector. The profile encompasses global company strategy, portfolio an
Market: Health Care
|
2008 |
5.700,00$ |
Stakeholder Opinions: Novel Therapeutic Approaches in Cardiovascular Medicine - Lack of market prospects for biologics expose an opportunity for cell and gene therapies
Analysis of the current unmet needs in cardiovascular disease markets / / Opinion leader commentary on key clinical trials and market landscape / / Review of the clinical and commercial status of stem cell therapy for cardiovascular disease / / Review of the clinical and commercial status of gene
Market: Health Care
|
2008 |
7.600,00$ |
Novo Nordisk A/S: PharmaVitae Profile
This analysis examines the historical and forecast performance for Novo Nordisk in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and
Market: Health Care
|
2008 |
5.700,00$ |
